Company Directory / biotech/health

PublicFor profitbiotech/healthFremont, China
3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.
Size
501-1000 people: larger than 95% of companies with a size listed
Age
16 years old.
Reach
No web traffic ranking listed.
BiopharmaBiotechnologyHealth CarePharmaceutical
Funding, as listed
$506M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about 3D Medicines, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
3D Medicines may be growing as evidenced by their recent licensing agreements with other pharmaceutical companies. The company has entered into a pact with Glenmark to license a cancer drug, which suggests an expansion of their product reach and potential revenue streams. Additionally, the collaboration with Jiangsu Alphamab indicates a strategic move to enhance their market presence in the pharmaceutical sector. These partnerships are indicative of 3D Medicines' active role in the biopharma and biotechnology industries, as they work to improve cancer diagnostics and treatments.
Summaries written by the source dataset, not by us, and not checked.
biotech/health in China.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.